ISRCTN ISRCTN13964268
DOI https://doi.org/10.1186/ISRCTN13964268
Protocol serial number N/A
Sponsor Fogarty International Center (FIC) (USA)
Funder Fogarty International Centre (FIC) (USA) (grant ref: TW007375)
Submission date
13/11/2005
Registration date
02/12/2005
Last edited
18/03/2008
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Infections and Infestations
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr Justus Byarugaba
Scientific

Makerere Univeristy
Faculty of Medicine
Department of Pediatrics and Child Health
P.O. Box 7072
Kampala
-
Uganda

Phone +256 75 696 633
Email byarugabaj@yahoo.com

Study information

Primary study designInterventional
Study designRandomised double blind clinical trial
Secondary study designRandomised controlled trial
Scientific title
Study acronymFIC
Study objectivesThe proportion of convulsions terminated by buccal midazolam is higher than the proportion of convulsions terminated by rectal diazepam in children.
Ethics approval(s)Ethics approved received from:
1. The Makerere University Medical School Research and Ethics Review Board (Uganda)
2. National Council of Science and Technology Institutional Review Board (IRB) (Uganda)
3. University of California San Francisco Institutional Review Board (IRB) (USA)
Health condition(s) or problem(s) studiedProlonged convulsions
InterventionRectal diazepam versus buccal placebo
Intervention typeDrug
PhaseNot Specified
Drug / device / biological / vaccine name(s)Midazolam, diazepam
Primary outcome measure(s)

Time taken to terminate convulsion within 10 minutes without re-occurence of the convulsion in an hour.

Key secondary outcome measure(s)

1. Time taken to re-occurence of convulsion after initial control
2. Time taken to terminate the convulsion within 10 minutes
3. Proportion of children who get respiratory depression within one hour after adminstration of the study drug

Completion date20/05/2006

Eligibility

Participant type(s)Patient
Age groupChild
Lower age limit3 Months
Upper age limit12 Years
SexAll
Target sample size at registration350
Key inclusion criteria1. Age between 3 months to 12 years
2. Admission to Acute Care Unit during the study period
3. A child who presents to the Acute Care Unit with convulsions
4. Provision of informed consent to continue participation in the study
Key exclusion criteria1. Documented evidence of having recieved parenteral anticonvulsant in the past 24 hours
2. Cessation of convulsion before adminstration of study drug
3. Parent/caretaker verbally declines to participate in the study
Date of first enrolment20/11/2005
Date of final enrolment20/05/2006

Locations

Countries of recruitment

  • Uganda

Study participating centre

Makerere Univeristy
Kampala
-
Uganda

Results and Publications

Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article Results 01/01/2008 Yes No